Clinical Trials Directory

Trials / No Longer Available

No Longer AvailableNCT03906318

Expanded Access Use of Itacitinib to Treat a Single Patient With Aplastic Anemia

Status
No Longer Available
Phase
Study type
Expanded Access
Enrollment
Sponsor
Incyte Corporation · Industry
Sex
Age
Healthy volunteers

Summary

Expanded Access Use of Itacitinib to Treat a Single Patient With Aplastic Anemia

Conditions

Interventions

TypeNameDescription
DRUGIticitinib

Timeline

First posted
2019-04-08
Last updated
2022-09-30

Source: ClinicalTrials.gov record NCT03906318. Inclusion in this directory is not an endorsement.